On 29 January 2019, Stefan Luitz filed an appeal at the CAS against the Challenged Decision. A hearing took place in the presence of the parties on 11 March 2019 at the CAS headquarters in Lausanne, Switzerland.
The CAS Panel in charge of this matter noted that Article 20.4 FIS ADR provides that the World Anti- Doping Code (WADC) and its International Standards shall prevail over the FIS ADR in case of a conflict. Since the WADC and Prohibited List provide that the inhalation of supplemental oxygen does not constitute an Anti-Doping Rule violation, the CAS Panel considered that Article 2.12 FIS ADR was in conflict with, and thus overridden by the WADC.
The CAS issued only the operative part of the decision today. The reasoned award with the grounds for the Panel’s unanimous decision is being finalised and will be notified to the parties as soon as possible.